NCT07651943

Brief Summary

The goal of this prospective observational study is to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images. The main questions it aims to answer are: whether AI assistance improves the diagnostic performance of ophthalmologists in detecting retinal findings on UWF retinal images; whether AI assistance improves sensitivity, specificity, and inter-reader agreement across clinicians with different levels of experience. Approximately 600 UWF retinal images prospectively collected from multiple ophthalmic centers in China will be included. Images will be independently annotated by expert retinal specialists to establish reference labels for retinal finding categories. Four ophthalmologists with different levels of clinical experience, including one senior retinal specialist and three junior ophthalmologists, will participate in a crossover multi-reader study. For each clinician, the dataset will be randomly divided into two equal subsets. During the first reading session, clinicians will evaluate one subset without AI assistance and the other subset with AI assistance. After a washout interval of at least two weeks, the reading conditions will be reversed in a second reading session with independently randomized image order. Under the AI-assisted condition, clinicians will be provided with category-level AI prediction probabilities for retinal findings. No localization maps, heatmaps, segmentation overlays, or automated diagnostic recommendations will be displayed. Clinicians will retain full autonomy over final decisions. Reader performance under AI-assisted and unaided conditions will be compared using expert reference annotations as the ground truth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
462

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

1 month

First QC Date

June 5, 2026

Last Update Submit

June 10, 2026

Conditions

Keywords

Artificial IntelligenceUltra-Widefield ImagingRetinal ImagingReader StudyDiagnostic PerformanceAI-Assisted Diagnosis

Outcome Measures

Primary Outcomes (2)

  • Sensitivity for retinal finding detection

    Sensitivity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions using expert annotations as the reference standard.

    through study completion, an average of 2 months

  • Specificity for retinal finding detection

    Specificity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions.

    through study completion, an average of 2 months

Secondary Outcomes (3)

  • Area under the receiver operating characteristic curve (AUC)

    through study completion, an average of 2 months

  • Inter-reader agreement

    At study completion (up to 3 months)

  • Diagnostic performance improvement among junior ophthalmologists

    At study completion (up to 3 months)

Study Arms (2)

AI-Assisted Interpretation

Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.

Device: AI-Assisted Interpretation

Unaided Interpretation

Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.

Device: Unaided Interpretation

Interventions

Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.

AI-Assisted Interpretation

Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.

Unaided Interpretation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants undergoing clinically indicated ultra-widefield retinal imaging at participating ophthalmic centers in China, including individuals with diverse retinal diseases and retinal findings encountered in real-world clinical practice.

You may qualify if:

  • Participants undergoing ultra-widefield retinal imaging at participating ophthalmic centers;

You may not qualify if:

  • Poor-quality or ungradable retinal images;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Chongqing Huaxia Eye Hospital

Chongqing, Chongqing Municipality, China

Location

Fuzhou Eye Hospital

Fuzhou, Fujian, 361000, China

Location

Xiamen Eye Center of Xiamen University

Xiamen, Fujian, 361000, China

Location

Hengshui Tongrui Eye Hospital

Hengshui, Hebei, China

Location

Heze Huaxia Eye Hospital

Heze, Shandong, China

Location

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Xiuju Chen

    Xiamen Eye Center of Xiamen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 16, 2026

Study Start

January 1, 2026

Primary Completion

February 1, 2026

Study Completion

February 10, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data underlying the results reported in this study, including retinal imaging data and associated annotations, may be made available upon reasonable request to the corresponding investigator following publication, subject to institutional ethics approval, data-sharing agreements, and applicable data governance and privacy regulations.

Locations